New implant aims to ease chronic pain for years

NCT ID NCT07507422

Recruiting now Symptom relief Sponsor: Medtronic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking 970 adults with chronic pain who receive an Inceptiv™ spinal cord stimulator, a device that sends mild electrical pulses to the spine to block pain signals. Researchers want to see if at least half of patients get significant pain relief and better quality of life over six months and beyond. The goal is to confirm the device works well in real-world use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Inceptiv™ spinal cord stimulator (implantable device)
What this could lead to: If successful, this could confirm that the Inceptiv™ device provides lasting pain relief and improves quality of life for people with chronic pain.
What could go wrong: This is an observational post-market study, not a controlled trial, so results may be influenced by other factors. The device also carries surgical risks like infection or lead movement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Pain, Intractable

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN INTRACTABLE PAIN

Contacts and locations

Locations

Center for Pain and Supportive Care
RECRUITING

Phoenix, Arizona, 85028, United States
Christian Hospital
RECRUITING

St Louis, Missouri, 63136-6119, United States
North Texas Orthopedics and Spine Center
RECRUITING

Houston, Texas, 76051-3930, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.